Skip to main content

Table 4 Moderating effect of omega-6 PUFAs on the association of TSE and current asthma

From: Effect of polyunsaturated fatty acids intake on the occurrence of current asthma among children and adolescents exposed to tobacco smoke: NHANES 2007–2018

Variables

Crude model**

Model 5

Model 6

AOR (95% CI)

P

AOR (95% CI)

P

AOR (95% CI)

P

Cotinine

1.66 (1.29–2.12)

 < 0.001

1.53 (1.19–1.97)

0.001

1.35 (1.01–1.83)

0.048

Omega-6 PUFAs

1.21 (0.91–1.62)

0.193

1.16 (0.86–1.57)

0.314

1.24 (0.92–1.69)

0.161

Cotinine * Omega-6 PUFAs

0.88 (0.59–1.31)

0.523

0.87 (0.58–1.31)

0.505

0.88 (0.58–1.34)

0.546

  1. AOR adjusted odds ratio, CI confidence interval, Ref reference, PUFAs polyunsaturated fatty acids, TSE tobacco smoke exposure;
  2. Crude Model**: only adjusted serum cotinine, omega-6 PUFAs and serum cotinine*omega-6
  3. Model 5: adjusted serum cotinine, omega-6 PUFAs, serum cotinine*omega-6 PUFAs, age, gender and race
  4. Model 6: adjusted serum cotinine, omega-6 PUFAs, serum cotinine*omega-6 PUFAs, age, gender, race, sedentary time, overweight, relative asthma and hay fever